Papers

Peer-reviewed articles:

Haddad LB, Philpott S, Schonfeld T. Contraception and prevention of HIV transmission: a conflict of public health principles. Journal of Family Planning and Reproductive Health Care 2015; 41(1): 20-3.

Madhivanan P, Krupp K, Kulkarni V, Kulkarni S, Vaidya N, Shaheen R, Philpott S, Fisher C. HIV testing among pregnant women living with HIV in India: Are private healthcare providers routinely violating women’s human rights? BMC International Health and Human Rights 2014; 14:7. doi:10.1186/1472-698X-14-7.

Philpott S. Execution by Lethal Injection: Illegal Research? Hastings Center Report 2014; 44(2): 11-2.

Silverman H, Strosberg M, Luna F, Philpott S, Hammerle CA. An analysis of online courses in research ethics in the Fogarty-sponsored bioethics training programs. Journal of Empirical Research in Human Research Ethics 2013; 8(5): 59-74.

Strosberg M, Gefenas E, Loue S, Philpott S. Building research ethics capacity in post-Communist countries: Experience of two Fogarty training programs. Journal of Empirical Research in Human Research Ethics 2013; 8(5): 28-39.

Kalfoglou AL,  Kammersell MR, Philpott S, Dahl E. Ethical arguments for and against sperm sorting for non-medical sex selection: A review. Reproductive BioMedicine 2013; http://dx.doi.org/10.1016/j.rbmo.2012.11.007.

Philpott S. Social justice, public health ethics, and the use of pre-exposure prophylaxis for HIV prevention. American Journal of Preventative Medicine 2013; 44(1) Suppl 2: S137-40.

Philpott S. Research, Unethical. In Jennings B, et al. (eds). 2013. Encyclopedia of Bioethics. Farmington Hills, MI: Cengage.

Schüklenk U, Philpott S. International research ethics. In LaFollette H, Deigh J, Stroud S, LaFollette E (eds). 2013. International Encyclopedia of Ethics. Hoboken, NJ: Wiley-Blackwell.

Rhodes R, Azzouni J, Baumrin, et al. De minimis risk: A new category of research risk. American Journal  of Bioethics 2011; 11(11): 1-7.

Flanigan B, Philpott S, Strosberg M. Protection of human participants enrolled in critical care research trials. Journal of Intensive Care Medicine 2011; 26(4): 237-49.

Purdy S, Aagaard AW, Philpott S. The review, approval, and marketing of biosimilars in the United States. Part 2: Ethical issues. BioProcess International 2011; 9(1): 14-19.

Philpott S. (Un)Risky business: Adolescents and HIV prevention trials. American Journal of Bioethics 2011; 11(6): 17-9.

Philpott S, McGrory E, Hankins C, Paxton L, Heise L, the Participants in the 2009 GCM/CDC/UNAIDS Consultation on Standards of Prevention in HIV Prevention Trials. Establishing clear standards of prevention in HIV prevention trials. Journal of Medical Ethics 2011; 27(4): 244-8.

Schüklenk U, Philpott S. AIDS: The time for changes in law and policy is now. International Journal of Law in Context 2011; 7(3): 305-17.

Philpott S, Baker R. Why Avandia proves bio pharma needs stronger ethical standards. Bioethics 2010; 24(8): ii-iii.

Philpott S, Schüklenk U. Medical research that never should have taken place. Bioethics Forum, 2010; May 5. Available online at http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4626&blogid=140.

Aagaard AW, Prudy S, Philpott S. The review, approval, and marketing of biosimilars in the United States. Part 1: Safety and regulatory issues. BioProcess International 2010; 8(11): 12-20.

McGrory E, Philpott S, Hankins C, Paxton L, Heise L. Standards of Prevention in HIV Prevention Trials: Consultation Report and Recommendations. Washington, DC: Global Campaign for Microbicides at PATH; 2010.

Gordon E, Philpott S. The convergence of research and clinical practice: How Institutional Review Boards review Humanitarian Use Device applications. Journal of Empirical Research on Human Research Ethics, 2008; 3(4):81-98.

Heise L, Philpott S. Predicting the unpredictable real-world impact of ARV-based microbicides. Proceeding National Academy of Sci USA, 2008;105(44):E73.

Kemal KS, Beattie T, Dong T, Weiser B, Kuiken C, Sutton J, Lang D, Yang H, Peng YC, Kaul R, Collman R, Philpott S, Rowland-Jones S, Burger H. Transition from long-term nonprogression to HIV-1 disease associated with escape from cellular immune control. Journal of Aquired Immune Deficiency Syndromes, 2008; 48(2):119-26.

Weiser B, Philpott S, Klimkait T, Burger H, Kitchen C, Bürgisser P, Gorgievski M, Perrin L, Piffaretti J-C, Ledergerber B, HIV Swiss Cohort Study. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during antiretroviral therapy. AIDS, 2008; 22(4):469-79.

Cardozo T, Kimura T, Philpott S, Weiser B, Burger H, Zolla-Pazner S. Structural basis of co-receptor selectivity in the HIV-1 V3 loop. AIDS Research and Human Retroviruses, 2007; 23(3): 415-26.

Fossett J, Ouellette A, Philpott S, Magnus D, McGee G. The bioethics of federalism: States and moral pluralism. Hastings Center Report, 2007; 37(6): 24-35.

Philpott S. The EPA’s Human Studies Review Board and the ethics of pesticide testing using human subjects. ASBH Exchange, 2006; 9(3): 3,7.

Chakraborty R, Reinis M, Rostron T, Philpott S, Dong T, D’Agostino A, Musoke R, de Silva E, Stumpf M, Weiser B, Burger H, Rowland-Jones SL. Nef gene sequence variation among HIV-1- infected African children. HIV Medicine, 2006; 7: 75-84.

Karchava M, Pulver W, Smith L, Philpott S, Sullivan TJ, Wethers J, Parker MM. Prevalence of drug resistance mutations and non-clade B strains in HIV-infected infants in New York State. Journal of Aquired Immune Deficiency Syndromes, 2006; 42(5):614-9.

Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson’s disease. Genetic Testing, 2006; 10(3): 221-7.

Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Falgout B, Ren P, Ferguson DM, Shi P-Y. Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrobial Agents and Chemotherapy, 2006; 50(4):1320-9.

Torian LV, Blank S, Kellerman SE, Frieden TR, Ho DD, Boden D, Markowitz M, Mullen M, Parker MM, Philpott S, Roome A, McKenna MR, Folks T, Heneine W. Investigation of a new diagnosis of multidrug-resistant, dual-tropic HIV-1 infection — New York City, 2005. Morbidity and Mortality Weekly Report, 2006; 55(29): 793-6.

Philpott S. Eggs, lies and compromise. American Journal of Bioethics 2005; 5: 1-2.

Philpott S, Burger H, Tsoukas C, Foley B, Anastos K, Kitchen C, Weiser B. Human immunodeficiency virus type 1 (HIV-1) genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. Journal of Virology, 2005; 79: 353-63.

McGee G, Shelton W, Philpott S. A pragmatic approach to the ethics of reproductive human cloning. New York State Bar Association Health Law Journal 2005; 10(3): 56-62.

McGee G, Philpott S, Kuhn V, Robertson-Kraft C. Patrizio P. Bioethics in embryonic research. In: Encyclopedia of life sciences, London: Nature Publishing Group, http://www.els.net/doi:10.1038/npg.els.0003486.

Schroeder T, Burger H, Weiser B, Bengualid V, Kimani J, Anzala AO, Parker M, Lamson D, Philpott S. Characterization of intersubtype recombinant HIV-1 genomes using a non-radioactive heteroduplex tracking assay. AIDS Research and Human Retroviruses, 2005; 21: 314-8.

Fang G, Weiser B, Kuiken C, Philpott S, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, Anzala O, Burger H.  Recombination following superinfection by HIV-1. AIDS, 2004; 18: 153-9.

Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen C-H, Kaul R, Anzala AO, Bwayo J, Kimani J, Philpott SM, Kitchen C, Sinsheimer JS, Gaschen B, Lang D, Shi B, Kemal KS, Rostron T, Brunner C, Beddows S, Sattenau Q, Paxinos E, Oyugi J, Burger H. Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations. Journal of Infectious Disease, 2004; 190: 697-701.

Kitchen CMR, Philpott S, Burger H, Weiser B, Anastos K, Suchard MA. Evolution of HIV-1 coreceptor usage during antiretroviral therapy: a Bayesian approach. Journal of Virology, 2004; 78: 11296-302.

Philpott S, Burger H, Tarwater P, Lu M, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young M, Miotti P, Dupuis M, Chen C-H, Weiser B. CCR2 genotype and disease progression in a treated population of HIV-1-infected women. Clinical Infectious Disease, 2004; 39: 861-5.

Shi B, Philpott S, Weiser B, Kuiken C, Fowke K, Fang G, Brunner C, Plummer F, Rowland-Jones S, Bwayo J, Kimani J, Anzala A, Burger H. Construction of an infectious molecular clone of HIV-1 from a patient with a subtype D-C recombinant virus. AIDS Research and Human Retroviruses, 2004; 20: 1015-8.

Philpott S, Weiser B, Tarwater P, Vermund SH, Kleeberger CA, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young MA, Miotti P, Dupuis M, Chen C-H, Burger H. CCR5 genotype and susceptibility to transmission of HIV-1 in women. Journal of Infectious Disease, 2003; 187:569-75.

Philpott SM. HIV-1 coreceptor usage, transmission, and disease progression. Current HIV Research 2003; 1: 217-27.

Kemal KS, Foley B, Burger H, Anastos K, Minkoff H, Kitchen C, Philpott SM, Gao W, Robison E, Holmes S, Dehner C, Beck S, Meyer WA 3rd, Landay A, Kovacs A, Bremer J, Weiser B. HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proceedings of the National Academy of Science USA, 2003; 100: 12972-12977.

Buehring GC, Philpott SM, Choi KY. Humans have antibodies reactive with bovine leukemia virus. AIDS Research and Human Retroviruses, 2003; 19: 1105-13.

Fang G, Weiser B, Kuiken C, Philpott S, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, Anzala O, Burger H.  Recombination following superinfection by HIV-1.  AIDS, 2003; 18: 153-9.

Chakraborty R, Gillespie GMA, Reinis M, Rostron T, Dong T, Philpott S, Burger H, Weiser B, Peto T, Rowland-Jones SL. HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate. AIDS, 2002; 16: 2085-7.

Philpott S, Weiser B, Anastos K, Ramirez-Kitchen CM, Robison E, Meyer WA, Sacks HS, Mathur-Wagh U, Brunner C, and Burger H.  Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.  Journal of Clinical Investigation, 2001; 107:431-438.

Philpott SM, Buehring GC. Defective DNA repair in cells infected with Human T-cell Leukemia Virus/Bovine Leukemia Viruses: Role of tax gene. Journal of the National Cancer Institute, 1999; 91: 933-942.

Philpott SM, Burger H, Charbonneau T, Grimson R, Vermund S, Visosky A, Nachman S, Kovacs A, Tropper P, Frey H, and Weiser B. CCR-5 genotype and resistance to vertical transmission of human immunodeficiency virus type 1. Journal of Aquired Immune Deficiency Syndromes, 1999; 21: 189-193.

Passaro DJ, Waring L, Armstrong R, Bolding F, Bouvier B, Rosenberg J, Reingold AW, McQuitty M, Philpott SM, Jarvis WR, Werner SB, Tompkins LS, Vugia DJ. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. Journal of Infectious Disease, 1997; 75: 992-995.

Philpott SM, Buehring GC. Induction of single-strand DNA breaks in cells infected with the Human T-cell Leukemia Virus or Bovine Leukemia Virus. Journal of Cellular Biochemistry, 1994; 18C: 216.

Books:

Balint J, Philpott S, Baker B, Strosberg M (eds). 2006. Advances in Bioethics, Vol. 9: Ethics and Epidemics. London, UK: Elsevier/JAI Press.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s